LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
29.73
+0.85 (2.94%)
May 2, 2025, 4:00 PM EDT - Market closed

LENZ Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
813794---
Enterprise Value
605578---
Last Close Price
29.5228.87---
Debt / Equity Ratio
0.010.010.010.01-
Asset Turnover
---0.46-
Quick Ratio
20.0920.093.554.6814.61
Current Ratio
20.3620.363.634.9114.62
Return on Equity (ROE)
-38.94%-38.94%-157.61%-39.80%-
Return on Assets (ROA)
-25.64%-25.64%-77.17%-20.07%-
Return on Capital (ROIC)
-28.47%-28.47%-101.31%-24.01%-
Buyback Yield / Dilution
-986.27%-986.27%79.28%-1.05%-
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q